Boehringer Ingelheim Kg

Boehringer Ingelheim International Gmbh

Boehringer Ingelheim Pharma Gmbh & Co Kg

Boehringer Ingelheim Pharma Kg

Boehringer Ingelheim Gmbh

Boehringer Ingelheim Vetmedica Gmbh

Boehringer International Gmbh

Other

Siemens Aktiengesellschaft

Ecole Polytechnique Federale De Lausanne

Orion Corporation

Celaflor Gmbh

Ingelheim Am Rhein

Celaflor Gmbii

Airsec S.a.s.

Bernd Zierenberg

Johannes Geser

Joachim Eicher

Dieter Hochrainer

Bernhard Freund

Gilbert Wuttke

Heinrich Kladders

Joerg Schiewe

Stefan Henke

Andreas Fiol

Joachim Jaeger

Arun R Gupte

Pasquale Cirillo

Matthias Hausmann

Martin Andreas Folger

Hubert Kunze

Michael Schyra

Bernhard Hassel

Martin Essing

Stephen Terence Dunne

Knut Elbers

Holger Reinecke

Hanshelmut Itzel

Christo A Drandarevski

Michael Krueger

Ralph Christian Reimholz

Uwe Rohr

Wilfried Heupt

Klaus Noehl

Stefan Kaulmann

Gojko Muacevic

Horst Wergen

Klaus Van Der Linden

Gunther Entenmann

Herbert Stricker

Paul Bowen

Guido Schmiedel

Didier Lancesseur

Otto Kern

Christian Golberg

Victor Brantl

Jacques Lemaitre

Mika Tapio Vidgren

Nathalie Jongen

Michael Diestelhorst

Isolde Martin

Jacques Lemaître

Marcel Donnet

Juergen Friedrich

Michael Herschel

Cristina Lucica Soare

Pekka J Karttunen

Raimo K Auvinen

Hans D Ruthemann

Michel Mikhail

Volkmar Haselbarth

Lucica Cristina Soare

Jörg Schiewe

A method for treating pain, inflammation, fever and respiratory complaints in mammals comprising administering by needleless injection to a mammal in need of such treatment an aqueous cyclodextrin-free solution of meloxicam containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base.

Highly concentrated stable meloxicam solutions for needleless injection

An aqueous cyclodextrin-free solution of meloxicam suitable is provided for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients.

A nebulizer having an insertable container and a monitoring device for counting actuations of the nebulizer is proposed. The monitoring device is mounted in a detachable housing part and directly detects movements of container during a nebulizing process, an air supply current in the region of a mouthpiece, and/or the production of aerosol, in order to detect this as the actual dispensing of fluid and actuation of the nebulizer, while preferably the time of actuation of the nebulizer is additionally detected and stored. This allows better monitoring and guidance for the user.

Nebulizer

The invention relates to an improved process for the production of powders of an inhalable medicament by crystallization from a supersaturated fluid containing said medicament, the method comprising passing along a tubular reactor

Process for the manufacture of powders of inhalable medicaments

The invention relates to ethanol-containing pharmaceutical preparations for the production of propellant-free aerosols.

Stable pharmaceutical budesonide preparation for producing propellant-free aerosols

An inhalation kit comprising: (a) an inhaler displaying a flow resistance of about 0.01 to 0.1 &#x221a;{square root over (kPa)} min/L; and (b) an inhalable powder comprising tiotropium in admixture with a physiologically acceptable excipient with an average particle size of between 10 to 500 &#x3bc;m, and a method of administering an inhalable powder containing tiotropium in admixture with a physiologically acceptable excipient with an average particle size of between 10 &#x3bc;m to 500 &#x3bc;m, the method comprising actuating an inhaler a flow resistance of about 0.01 to 0.1 &#x221a;{square root over (kPa)} min/L containing the inhalable powder.

Method for the administration of an anticholinergic by inhalation

Foil bags are used as a primary packaging for liquids, the bags permitting the liquid to be taken therefrom without the application of a considerable amount of force. A container is provided for a medicinal liquid, the container being gas-tight and liquid-tight so that it is storable over many months. The container includes a collapsible foil bag on which a flange, which is stable in respect of shape, is disposed. The flange is designed for fitting onto a discharge connection member. The container can be disposed in a casing which is stable in respect of shape. The medicinal liquid does not come into contact with air and is protected from the effect of light. The medicinal liquid may be dispensed from the foil bag in many partial quantities over a prolonged period of time, with a respective partial amount thereof being converted into an aerosol by means of an atomizer.

Container for a medicinal liquid

For meteredly dispensing a liquid over a period of several months from a container which can be stored over a long period of time, the need is for a container which is practically diffusion-tight and in which the liquid does not come into contact with the ambient atmosphere. The cartridge according to the invention is a three-shell container comprising a collapsible bag which contains the liquid, a container which is stable in respect of shape and a stiff metal casing. The cartridge can be releasably connected to a dispensing device. The cartridge can be provided with a micro-opening with which the time for pressure equalisation between the cartridge and the ambient atmosphere can be adjusted. The cartridge is suitable for aqueous and for alcoholic liquids which contain a pharmaceutically active substance. The liquid in the cartridge is protected from external influences. The cartridge can be used in an atomiser for producing an inhalable aerosol for the treatment of illnesses.

Cartridge for a liquid

A dry powder inhaler () is to be made available, with which a particle size and particle size distribution preferred for inhalation are to be achieved and by means of which as high a line particle fraction as possible is to be realized. This is achieved by means of a dry powder inhaler () that is characterized in that provided in the inhaler () is a nozzle () through which the aerosol () flows before leaving the inhaler ().

Dry powder inhaler

The present invention relates to a propellant-gas-free apparatus for the dispensing of liquids, a container cartridge suitable for this for storing the liquid and the ensemble comprising both. The invention comprises a device for the exertion of pressure and for accommodating a container cartridge and a container cartridge in which the dispensing facility is integrated.

Apparatus for the dispensing of liquids, container cartridge suitable for this, and system comprising the apparatus for the dispensing of liquids, and the container cartridge

A nebulizer for a fluid and a container holding the fluid which is insertable in the nebulizer are proposed. To improve safety in use it is proposed that the nebulizer comprises first coding means and the container is associated with second coding means, so that the container can only be inserted in the nebulizer or used therewith if the codes match. Preferably, the code associated with the container comprises clear identification of the fluid contained in the container.

The present invention relates to pharmaceutical preparations in the form of aqueous solutions for the production of propellant-free aerosols.

Method for the production of propellant gas-free aerosols from aqueous medicament preparations

Atomizers for administering liquids to the cornea or conjunctiva of the eye, special eye adapters for atomizers and the use of atomizers for ophthalmological administration. The atomizers are free from propellant gas and have an energy reservoir for supplying the energy needed for the atomization process.

Atomizer for applying liquids onto eyes

Growing community of inventors

Bingen am Rhein, Germany

Bernd Zierenberg